MAXIMIZING ONCOLOGY EXPLORATION WITH BUILT-IN KRAS ASSAY PROVIDERS AND RAS ASSAYS

inside the rapidly evolving industry of oncology analysis, correct and successful mutation screening is important for acquiring focused therapies. The KRAS solutions System plays a pivotal role in this landscape by offering comprehensive methods for KRAS mutation profiling and analysis. KRAS mutations, found in around 95% of RAS-similar oncogenic a